Literature DB >> 28576707

Development of transcripts regulating dendritic spines in layer 3 pyramidal cells of the monkey prefrontal cortex: Implications for the pathogenesis of schizophrenia.

Samuel J Dienel1, Holly H Bazmi2, David A Lewis3.   

Abstract

Certain cognitive deficits in schizophrenia appear to emerge from altered postnatal development of the dorsolateral prefrontal cortex (DLPFC). Dendritic spines on DLPFC layer 3 pyramidal cells are essential for certain cognitive functions, change in density over development, and are reduced in number in schizophrenia. Altered expression of molecular regulators of actin filament assembly and stability, which are essential for spine formation and maintenance, is thought to contribute to the pathogenesis of spine deficits in the disease. However, the normal developmental expression patterns of these molecular regulators of dendritic spines, which might provide insight into the timing of spine deficits in schizophrenia, are unknown. Therefore, we quantified the expression from birth to adulthood of key transcripts regulating dendritic spine density in monkey DLPFC. Layer 3 pyramidal cells, and tissue samples containing layers 3 or 6, were captured by laser microdissection and selected transcripts were quantified using PCR. In layer 3 pyramidal cells, the expression levels of most of the transcripts studied changed early, and not late, in postnatal development. These developmental shifts in expression were generally not detected in tissue homogenates of layers 3 or 6, suggesting that the changes may be enriched in layer 3 pyramidal cells. The timing of these shifts in expression suggests that early, rather than later, postnatal development may be a vulnerable period for layer 3 pyramidal neurons. Disruption of the normal developmental trajectories of these transcripts may contribute to layer 3 pyramidal neuron spine deficits in individuals who are later diagnosed with schizophrenia.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDC42; Dendritic spines; Development; Layer 3; Pyramidal cells; Schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28576707      PMCID: PMC5542021          DOI: 10.1016/j.nbd.2017.05.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  59 in total

1.  Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin.

Authors:  Ernesto Andrianantoandro; Thomas D Pollard
Journal:  Mol Cell       Date:  2006-10-06       Impact factor: 17.970

Review 2.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

3.  Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder.

Authors:  Glenn T Konopaske; Nicholas Lange; Joseph T Coyle; Francine M Benes
Journal:  JAMA Psychiatry       Date:  2014-12-01       Impact factor: 21.596

4.  Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits.

Authors:  Masayuki Ide; David A Lewis
Journal:  Biol Psychiatry       Date:  2010-04-10       Impact factor: 13.382

5.  Synaptogenesis in the prefrontal cortex of rhesus monkeys.

Authors:  J P Bourgeois; P S Goldman-Rakic; P Rakic
Journal:  Cereb Cortex       Date:  1994 Jan-Feb       Impact factor: 5.357

Review 6.  GABAergic Function as a Limiting Factor for Prefrontal Maturation during Adolescence.

Authors:  Adriana Caballero; Kuei Y Tseng
Journal:  Trends Neurosci       Date:  2016-05-24       Impact factor: 13.837

7.  Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.

Authors:  Thomas M Hyde; Barbara K Lipska; Towhid Ali; Shiny V Mathew; Amanda J Law; Ochuko E Metitiri; Richard E Straub; Tianzhang Ye; Carlo Colantuoni; Mary M Herman; Llewellyn B Bigelow; Daniel R Weinberger; Joel E Kleinman
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

Review 8.  Dendritic spine pathology in schizophrenia.

Authors:  J R Glausier; D A Lewis
Journal:  Neuroscience       Date:  2012-04-27       Impact factor: 3.590

9.  Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; John P Corradi; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-04-11       Impact factor: 13.382

10.  Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice.

Authors:  Mansuo L Hayashi; Se-Young Choi; B S Shankaranarayana Rao; Hae-Yoon Jung; Hey-Kyoung Lee; Dawei Zhang; Sumantra Chattarji; Alfredo Kirkwood; Susumu Tonegawa
Journal:  Neuron       Date:  2004-06-10       Impact factor: 17.173

View more
  5 in total

1.  CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

Authors:  O M Ogundele; C C Lee
Journal:  Brain Res Bull       Date:  2017-11-11       Impact factor: 4.077

Review 2.  Cognitive Dysfunction and Prefrontal Cortical Circuit Alterations in Schizophrenia: Developmental Trajectories.

Authors:  Samuel J Dienel; Kirsten E Schoonover; David A Lewis
Journal:  Biol Psychiatry       Date:  2022-03-10       Impact factor: 12.810

3.  Postnatal Development of Glutamate and GABA Transcript Expression in Monkey Visual, Parietal, and Prefrontal Cortices.

Authors:  Gil D Hoftman; H Holly Bazmi; Andrew J Ciesielski; Liban A Dinka; Kehui Chen; David A Lewis
Journal:  Cereb Cortex       Date:  2021-03-05       Impact factor: 5.357

4.  Distinct Laminar and Cellular Patterns of GABA Neuron Transcript Expression in Monkey Prefrontal and Visual Cortices.

Authors:  Samuel J Dienel; Andrew J Ciesielski; Holly H Bazmi; Elizabeth A Profozich; Kenneth N Fish; David A Lewis
Journal:  Cereb Cortex       Date:  2021-03-31       Impact factor: 5.357

5.  Re-exploring the core genes and modules in the human frontal cortex during chronological aging: insights from network-based analysis of transcriptomic studies.

Authors:  Mulin Xu; Yu Liu; Yi Huang; Jinli Wang; Jinhua Yan; Le Zhang; Cuntai Zhang
Journal:  Aging (Albany NY)       Date:  2018-10-20       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.